Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Recurrence 1Melanoma 1Lymphoma 1Leukemia 1Hodgkin Disease 1

Interventions

Doxorubicin 13Bleomycin 12Vinblastine 11Prednisone 11Vincristine 10Etoposide 10Cyclophosphamide 10Radiotherapy 9Filgrastim 9Dacarbazine 7Procarbazine 6Granulocyte Colony-Stimulating Factor 5Dexamethasone 5ABVD protocol 5Vinorelbine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Gemcitabine 4Cytarabine 4Cisplatin 4Carmustine 4etoposide phosphate 3Mechlorethamine 3Ifosfamide 3indolepropanol phosphate 2Whole-Body Irradiation 2Positron Emission Tomography Computed Tomography 2Polymerase Chain Reaction 2Podophyllotoxin 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hodgkin Disease × Interleukin-2 × Clear all
NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Children's Oncology Group

Phase 2/3 Completed
24 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡